Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis

NCT01806662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Ustekinumab
OTHER: Placebo

Sponsor

Rockefeller University